NextCell Pharma AB banner
N

NextCell Pharma AB
F:65G

Watchlist Manager
NextCell Pharma AB
F:65G
Watchlist
Price: 0.0793 EUR -1.98%
Market Cap: €9.5m

Wall St Price Targets

65G Price Targets Summary
NextCell Pharma AB

Wall Street analysts forecast 65G stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 65G is 0.2332 EUR with a low forecast of 0.2309 EUR and a high forecast of 0.24 EUR.

Lowest Forecast
Price Target
0.2309 EUR
191% Upside
Average Forecast
Price Target
0.2332 EUR
194% Upside
Highest Forecast
Price Target
0.24 EUR
203% Upside
NextCell Pharma AB Competitors:
Price Targets
QNST
Quinstreet Inc
27% Upside
VAC
Pierre et Vacances SA
16% Upside
UFPT
UFP Technologies Inc
32% Upside
VYNE
Vyne Therapeutics Inc
235% Upside
SHLS
Shoals Technologies Group Inc
66% Upside
CDNA
CareDx Inc
5% Upside
AFYA
Afya Ltd
21% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for NextCell Pharma AB

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for NextCell Pharma AB

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for NextCell Pharma AB

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for NextCell Pharma AB

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Net Income Forecast
is not available for NextCell Pharma AB
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 65G's stock price target?
Price Target
0.2332 EUR

According to Wall Street analysts, the average 1-year price target for 65G is 0.2332 EUR with a low forecast of 0.2309 EUR and a high forecast of 0.24 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett